These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis. Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525 [TBL] [Abstract][Full Text] [Related]
3. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
6. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026 [TBL] [Abstract][Full Text] [Related]
7. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related]
8. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis. Swetha RG; Sandhya M; Ramaiah S; Anbarasu A J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038 [TBL] [Abstract][Full Text] [Related]
9. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Titball RW; Burtnick MN; Bancroft GJ; Brett P Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210 [TBL] [Abstract][Full Text] [Related]
15. Development of Burkholderia mallei and pseudomallei vaccines. Silva EB; Dow SW Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691 [TBL] [Abstract][Full Text] [Related]
16. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines]. Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574 [TBL] [Abstract][Full Text] [Related]
17. T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis. Reynolds C; Goudet A; Jenjaroen K; Sumonwiriya M; Rinchai D; Musson J; Overbeek S; Makinde J; Quigley K; Manji J; Spink N; Yos P; Wuthiekanun V; Bancroft G; Robinson J; Lertmemongkolchai G; Dunachie S; Maillere B; Holden M; Altmann D; Boyton R J Immunol; 2015 May; 194(10):4814-24. PubMed ID: 25862821 [TBL] [Abstract][Full Text] [Related]
18. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]